Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme

Clinical trial NCT00165477 · COMPLETED

Trial details

NCT number: NCT00165477
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Gliosarcoma Malignant Gliomas

Start date: 2005-09-01
Primary completion: 2007-11-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.